https://pharmadog.xyz/news/531775 pharmadog en 2026-10-12T17:08:13.000Z Asahi Kasei Therapeutics receives FDA approval for HSV drug acquired in $1 billion deal https://pharmadog.xyz/news/531671 pharmadog en 2026-10-12T15:58:00.000Z Aspen Neuroscience files for Nasdaq IPO to fund Parkinson’s cell therapy program https://pharmadog.xyz/news/531415 pharmadog en 2026-10-12T15:35:00.000Z Bristol Myers' lung drug admilparant meets Phase 3 goal at low dose, high dose falls short https://pharmadog.xyz/news/531351 pharmadog en 2026-10-12T15:12:41.000Z Mirum's Livmarli cuts itching in ultra-rare liver disease trial, showing significant benefit https://pharmadog.xyz/news/531375 pharmadog en 2026-10-12T15:04:54.000Z BMS lung drug meets low-dose endpoint in Phase 3 but high dose fails to improve lung function https://pharmadog.xyz/news/531352 pharmadog en 2026-10-12T15:04:37.000Z Bristol Myers reports two Phase 3 successes for fibrosis and RayzeBio drug https://pharmadog.xyz/news/531183 pharmadog en 2026-10-12T14:52:00.000Z Bausch + Lomb CEO Brent Saunders abruptly departs after failed multibillion-dollar sale https://pharmadog.xyz/news/531184 pharmadog en 2026-10-12T14:48:57.000Z GSK allocates over $800 million to expand R&D and manufacturing hub in Pennsylvania https://pharmadog.xyz/news/531039 pharmadog en 2026-10-12T13:34:43.000Z RevMed's pancreatic cancer drug Rasonque shows mixed results across KRAS subtypes, analysts stay optimistic https://pharmadog.xyz/news/531040 pharmadog en 2026-10-12T13:24:52.000Z BMS reports Phase 3 success for RYZ101 in GEP-NET trial https://pharmadog.xyz/news/531079 pharmadog en 2026-10-12T13:16:00.000Z Pharma faces $500B risk as patents expire, with Merck most exposed by 2028 https://pharmadog.xyz/news/531674 pharmadog en 2026-10-12T12:09:00.000Z Bausch + Lomb appoints board chair Thomas Appio as interim CEO after Brent Saunders departs https://pharmadog.xyz/news/530703 pharmadog en 2026-10-12T11:21:45.000Z GSK to invest $800 million in new biologics manufacturing hub in Pennsylvania https://pharmadog.xyz/news/530679 pharmadog en 2026-10-12T11:00:35.000Z Undecimal Bio raises $18 million to expand siRNA platform beyond liver diseases https://pharmadog.xyz/news/530990 pharmadog en 2026-10-12T09:42:00.000Z Roche reports updated eye drug data and FDA filing acceptance, targets July 2027 decision https://pharmadog.xyz/news/530991 pharmadog en 2026-10-12T09:25:00.000Z Tortugas Neuroscience's obuprazine shows significant improvement in phase 2b schizophrenia trial in China https://pharmadog.xyz/news/530822 pharmadog en 2026-10-12T08:06:00.000Z BMS reports phase 3 successes in IPF drug and neuroendocrine tumor radiotherapy https://pharmadog.xyz/news/530031 pharmadog en 2026-10-12T07:00:00.000Z Strategic CDMO partnerships shift from transactional to collaborative, emphasizing risk sharing and regulatory expertise https://pharmadog.xyz/news/529587 pharmadog en 2026-10-12T05:01:00.000Z Integrating Multiple Stability Measurements Improves Early Biologics Testing https://pharmadog.xyz/news/529982 pharmadog en 2026-10-12T02:55:00.000Z Merck’s deeper dive into efficacy, safety of $1.3B eye disease drug raises fears of ‘limited’ potential https://pharmadog.xyz/news/528111 pharmadog en 2026-10-11T21:00:05.000Z AstraZeneca attributes Phase 3 failure of bone disease enzyme therapy to trial design flaws https://pharmadog.xyz/news/523919 pharmadog en 2026-10-10T23:01:00.000Z Americans show higher trust in science than most countries, survey finds